Atypical hemolytic uremic syndrome with diacylglycerol kinase epsilon (DGKE) gene mutation

Arvind Bagga(All India Institute of Medical Sciences), Aditi Sinha, Priyanka Khandelwal(Chacha Nehru Bal Chikitsalaya), Aditi Sharma(Army Hospital Research and Referral), Sidharth Kumar Sethi(Medanta The Medicity), Pankaj Hari(Indian Council of Medical Research), Menka Yadav(Lady Hardinge Medical College)
Asian Journal of Pediatric Nephrology
January 1, 2019
10.4103/ajpn.ajpn_27_19
Cited by 4

Related Papers

Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicentre, multinational, observational cohort study
|The Lancet Child & Adolescent Health|2017|722
Patients with Mutations in NPHS2 (Podocin) Do Not Respond to Standard Steroid Treatment of Nephrotic Syndrome
|Journal of the American Society of Nephrology|2004|415
Clinical Features of Anti-Factor H Autoantibody–Associated Hemolytic Uremic Syndrome
|Journal of the American Society of Nephrology|2010|296
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|256
Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children
|Kidney International|2013|216